Answers are grounded in this paper and cite their sources.
Evaluation finds no effectiveness of nano-curcumin in preventing chemotherapy side effects in metastatic colorectal cancer, suggesting further research is needed.
Nano-curcumin in dose of 40 mg thrice daily was not effective in prevention of neuropathy, HFS and hematologic adverse reactions induced by XELOX/FOLFOX-6 regimens. Further research with larger sample size on different nano-curcumin dosing schedules is suggested.
No takes yet. Share an insight, caveat, or question.
Abad et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: